| My Account | Subscribe | Contact Us | Donate |
Home
- Kris Freeman Skis for Olympic Gold
- Good Insulin Injection Practices
- Etiquette for People without Diabetes
- Diabetes Technology and Intimacy
- An American in the UK: Healthcare for Type 1s
You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
If you are a physician, educator and medical professional who focus on the treatment of diabetes, then this is the must have resource for you.
Finally! A fresh take on the “professional” journal. Each bi-monthly issue cuts through the jargon and presents the most important information you need to enhance your practice and assist your patients.
Each bi-monthly issue of Diabetes Health Professional is a self-contained handbook covering products, educational resources and the latest diabetes research, complimented by balanced editorial focused on medical news, drug prescription information, clinical practice recommendations and changing treatment options.
Each quarter we send you the latest, most updated research guides, product guides and educational resource guides available for you and your patients.
Each week the Diabetes Health E-Newsletter delivers links to the very latest in news, reviews, blogs and videos from Diabetes Health direct to your inbox.
As a subscriber you'll get access to the amazing Diabetes Health Digital Advantage™ so you can read the current issue of Diabetes Health magazine online wherever you are!
You can cancel your newsletter subscription at anytime by clicking "Unsubscribe" on the bottom of any newsletter you receive
Then enter your new email address in the above form and click "Subscribe"
Latest Kidney Care (Nephropathy) Articles
While tracking kidney function, the researchers noticed that the drugs had a dramatic effect on the eye damage that often accompanies type 1.
Two Drugs Disappoint as Type 1 Kidney Treatments, But Shine With Eyes
The theory of unintended consequences has gotten another boost. Although two drugs designed to slow the loss of kidney function in people with type 1 diabetes turned out to be busts, they had a wonderful but entirely unexpected side effect: Eye damage was reduced by 65 to 70 percent in the patients taking them.
Doctors have been using the two blood pressure drugs, enalapril and losartan, to slow the kidney damage caused by long-term type 1 diabetes. They are typically first prescribed about 15 years after diagnosis. But a five-year study that tracked 285 participants found virtually no difference in kidney function between those who took enalapril, those who took losartan, and those who were given a placebo. In other words, neither drug had the desired effect.
But while tracking kidney function, the researchers noticed that the drugs had a dramatic effect on the eye damage that almost always accompanies type 1. Compared to the placebo group, the group that took enalapril experienced 65 percent less eye damage, while those who took losartan experienced 70 percent less.
According to Dr. Michael Mauer, a professor of pediatrics and medicine at the University of Minnesota who led the study, the drugs could be a boon to type 1 patients who have begun to experience eye damage. The only drawback to either drug, each of which has a very good safety record, is the possibility of fetal damage if they are taken during pregnancy. He added that whether the drugs will prove effective against eye damage in people with type 2 diabetes is unknown and will require a separate study.
Categories: Eye Care (Retinopathy), Kidney Care (Nephropathy), Medications, Research, Type 1 Issues
Facebook
MySpace 
Digg
You May Also Be Interested In...
Click Here To View Or Post Comments
6 comments -
Aug 17, 2009 -
Email to a Friend
Send a link to this page to your friends and colleagues.